This twice-monthly newsletter highlights recently published research where Dana-Farber faculty are listed as first or senior authors. The information is pulled from PubMed and this issue notes papers published from July 1 through July 15.
Dr. Derek Holder provides two mini talks on reducing secondary risk after mile ischemic stroke by outlining the role of short term dual antiplatelet (DAPT) and primary care follow up.
Can movies with drug themes trigger brain circuit responses in individuals with substance use disorder? A Mount Sinai study finds that not only do certain brain regions activate preferentially for these individuals, but those regions could be targeted to make treatment for patients more effective.
At Mount Sinai's new Celiac Disease Program, patients can meet with a gastroenterologist, GI nutrition physician, health psychologist, and dietitian specializing in celiac disease. That integrated approach ensures patients’ clinical, dietary, and social-emotional needs are met.
Alzheimer Disease treatment and research has been advancing quickly recently and Dr. Erik Musiek provides and update and where we stand in diagnosing and treating Alzheimer Disease.